← All organizations

Immune-Onc Therapeutics Inc

For profitWebsite ↗

Also known as: Immune-Onc Therapeutics | Immune-Onc Therapeutics Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Sep 9, 2022

Timeline

2010s

Jun 1, 2016
Immune-Onc Therapeutics Inc— Founded

Drugs by trial phase (3 distinct, 4 trials)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT05508100Lead sponsorPhase 1Sep 9, 2022
NCT05309187Lead sponsorPhase 1Apr 30, 2022
NCT05309187Study directorPhase 1Apr 30, 2022
NCT05054348Lead sponsorPhase 1Sep 30, 2021
NCT05054348Study directorPhase 1Sep 30, 2021
NCT04372433Lead sponsorPhase 1Jul 31, 2020
NCT04372433Study directorPhase 1Jul 31, 2020

Details

Founded: Palo Alto, CA, US Jun 1, 2016
Last known activity: Sep 9, 2022